Integrity Drives Powerful Team Performances

While many clinical trial professionals struggle with the lack of clear career paths in the industry, there are tools, tactics, and best practices to help spot and leverage new opportunities. In this occasional series, we’ll hear from leading experts both in and outside the clinical trial industry as they offer insights on how to […]

Study: Certified CRAs on Average Perform Better than Non-Certified CRAs

Data collected and analyzed by CRA Assessments, LLC and the Association of Clinical Research Professionals (ACRP) show Clinical Research Associates (CRAs) certified by ACRP on average perform better than their non-certified counterparts in key competencies related to monitoring clinical trials. “Sponsors, CROs, sites and other partners in the clinical research process can rest assured that […]

CRA Assessments’ Data Shows ACRP-Certified Clinical Research Associates (CCRA®) Perform Better than Non-Certified CRAs in Key Competencies Related to Monitoring Clinical Trials

Data collected and analyzed by CRA Assessments, LLC and the Association of Clinical Research Professionals (ACRP) show Clinical Research Associates (CRAs) certified by ACRP on average perform better than their non-certified counterparts in key competencies related to monitoring clinical trials. “Sponsors, CROs, sites and other partners in the clinical research process can rest assured that […]

Updated GCDMP Emphasizes Importance of EDC System Selection

Data managers for clinical trials should pay attention to recent changes made to the Good Clinical Data Management Practices (GCDMP) section on selection of systems for electronic data capture (EDC), according to information provided by OnlineCRF on the main points in the revisions regarding decisions to be made in this arena. The GCDMP standard, […]

FDA Headquarters

FDA Urges Industry to Broaden Clinical Trial Diversity Efforts

Despite concerted policy efforts in recent years, a new U.S. Food and Drug Administration (FDA) draft guidance says “challenges to participation in clinical trials remain, and certain groups continue to be underrepresented in many clinical trials.” The draft guidance, “Enhancing the Diversity of Clinical Trial Populations–Eligibility Criteria, Enrollment Practices, and Trial Designs,” recommends new […]